Pine Bark
Pinus pinaster · a standardised bark extract, measured by its proanthocyanidins
All articles checked for accuracy against the GB NHC Register and all sources have citations with verified links to their relevant studies.
Pine bark extract is a highly defined botanical ingredient. WellsparQ lists the exact proanthocyanidin content so you know what the extract actually delivers.
This article explains what pine bark extract is, how WellsparQ measures and labels it, what is in the extract, and how to read the research fairly. It flags the regulatory position: a well-standardised botanical with mixed evidence and no permitted health claims for the botanical itself.
Ingredient Snapshot
- What it is
- A standardised bark extract from maritime pine, measured by its proanthocyanidin content.
- Where from
- Pinus pinaster (maritime pine), chiefly from south‑west France (Landes).
- Known for
- A defined botanical extract standardised for proanthocyanidins (OPCs); used as a supplement ingredient.
- In WellsparQ
- BrightSight ComplexPine Bark — 1250 mg (equivalent from extract)
- GlowMatrix CollagenPine bark — 78.9 mg
Pine bark extract is one of the more precisely defined botanicals in the supplement world — not a whole herb but a standardised extract, made from the bark of the French maritime pine and sold to a specified content of active compounds. That standardisation is the whole point, and it is exactly the detail WellsparQ puts on the label. As the BrightSight factsheet card notes, the bark is declared "providing 79 mg of proanthocyanidins per capsule — the standardisation is on the label".
The plant and the extract
The commercial material comes from the bark of Pinus pinaster (the maritime pine), grown notably in the Landes forest of south-west France. The bark is extracted and standardised to a defined content of proanthocyanidins — a family of condensed tannin polyphenols ¹². The best-known branded, patented standardised extract is Pycnogenol; "pine bark extract" is the general ingredient. WellsparQ declares the proanthocyanidin content, which is what makes the amount meaningful — 5 mg of a standardised compound tells you far more than a raw milligram of unstandardised bark. As a botanical extract it is naturally suitable for vegetarians and vegans; kosher and halal status follows the finished product's certification.
What is in it
| Group | Examples | Note |
|---|---|---|
| Proanthocyanidins (OPCs) | procyanidin oligomers of catechin/epicatechin | the standardised marker group; the label figure ¹² |
| Phenolic acids | caffeic, ferulic, p-coumaric acids | minor phenolics ¹ |
| Catechin / taxifolin | flavan-3-ol and flavonol | monomeric building blocks ¹ |
A 2015 study in Phytochemistry characterised the condensed tannins and carbohydrates in hot-water bark extracts of European softwoods, giving a sense of the polymeric proanthocyanidin chemistry involved ². "Proanthocyanidins" and "OPCs" (oligomeric proanthocyanidins) refer to the same family — chains of flavan-3-ol units — and they are what the standardisation counts.
How WellsparQ measures it
| WellsparQ product | Declared pine bark | Standardised active |
|---|---|---|
| BrightSight Complex | Pine Bark — 1250 mg (equivalent from extract) | providing 79 mg proanthocyanidins per capsule |
| GlowMatrix Collagen | Pine bark — 78.9 mg | providing 5 mg proanthocyanidins |
Source: WellsparQ Supplements Database. Two things are worth noting. First, the "1250 mg" figure in BrightSight is an equivalent-from-extract weight — the amount of raw bark the extract represents — while the meaningful, standardised number is the 79 mg of proanthocyanidins actually delivered. WellsparQ prints both, which is the honest way to declare a concentrated extract. Second, in GlowMatrix the standardisation (5 mg) is stated so that, as the card says, "the amount is meaningful".
The evidence — read as evidence
Pine bark extract has a sizeable but uneven research literature. The most careful reading comes from an independent systematic review:
- A Cochrane systematic review (2020), Pine bark (Pinus spp.) extract for treating chronic disorders, examined randomised trials across a range of conditions and concluded that the evidence was insufficient to support its use, with small studies of variable quality ³. This is the single most important reference for anyone tempted to overstate the ingredient.
- Other meta-analyses have looked at narrower questions — for example, an analysis of pine bark (Pycnogenol) and plasma lipids reported in Phytotherapy Research (2019) — but these too note limitations of study size and design ¹.
The honest summary: a well-defined, well-standardised extract with a lot of individual studies but an independent review verdict that the overall evidence is not strong. We report the studies as findings by named researchers, with the Cochrane caveat front and centre, and make no benefit claim. Rooted in nature. Backed by research — and candid when the research is inconclusive.
Safety and sensible use
Pine bark extract is generally well tolerated in trials, with mild digestive upset or dizziness occasionally reported ³. Standardised extracts have been used at a range of doses in studies. As with any concentrated botanical, anyone pregnant, breastfeeding, on anticoagulants or other medication, or with a bleeding disorder, should ask a GP or pharmacist first.
Where it fits
Pine bark is the standardised botanical done properly — declared by its proanthocyanidin content, not by a vague "extract" line. In BrightSight Complex and GlowMatrix Collagen it is a measured, honestly labelled component. We tell you exactly how much active is in each capsule, and we tell you, just as plainly, that the research is not settled. It's a lifestyle.
References
- The impact of Pycnogenol supplementation on plasma lipids in humans: A systematic review and meta-analysis of clinical trials. Phytotherapy Research, 2019 — PMID 30456865 (ncbi.nlm.nih.gov). ↩ Back to text
- Characterization of condensed tannins and carbohydrates in hot water bark extracts of European softwood species. Phytochemistry, 2015 — PMID 26547588 (ncbi.nlm.nih.gov) — proanthocyanidin chemistry of pine/softwood bark. ↩ Back to text
- Robertson N.U. et al. Pine bark (Pinus spp.) extract for treating chronic disorders. Cochrane Database of Systematic Reviews, 2020 — PMID 32990945 (ncbi.nlm.nih.gov) — evidence judged insufficient. ↩ Back to text